中华肾脏病杂志
中華腎髒病雜誌
중화신장병잡지
2013年
5期
352-357
,共6页
李镇洲%万建新%崔炯%陈俊%高娜%许艳芳%邹臻寰%尤丹瑜
李鎮洲%萬建新%崔炯%陳俊%高娜%許豔芳%鄒臻寰%尤丹瑜
리진주%만건신%최형%진준%고나%허염방%추진환%우단유
红细胞生成素%肾功能衰竭,慢性%大鼠,Sprague-Dawley%归巢因子
紅細胞生成素%腎功能衰竭,慢性%大鼠,Sprague-Dawley%歸巢因子
홍세포생성소%신공능쇠갈,만성%대서,Sprague-Dawley%귀소인자
Erythropoietin%Kidney failure,chronic%Rats,Sprague-Dawley%Homing factors
目的 观察红细胞生成素(EPO)对慢性肾衰竭(CRF)大鼠肾组织归巢因子表达的影响.方法 采用分阶段5/6肾切除制备大鼠CRF模型.实验动物随机分为3组:假手术组、CRF模型组和EPO治疗组.从第3周开始,治疗组大鼠每次皮下注射重组人EPO 50 IU/kg,每周3次,共6周.8周后检测各组大鼠血肌酐(Scr)、血尿素氮(BUN)、尿蛋白、血红蛋白(Hb);采用实时荧光定量PCR、Western印迹和免疫组化方法检测残肾组织EPO及其受体(EPOR)、归巢因子及其受体(SDF-1、CXCR4、Ang-1、Tie2、SCF、c-Kit)的表达.结果 与模型组比较,EPO治疗可上调残肾组织归巢因子及其受体(SDF-1、CXCR4、Ang-1、Tie2、SCF、c-Kit)mRNA和蛋白的表达(均P<0.05);同时,EPO治疗还可上调残肾组织EPO及EPOR的mRNA和蛋白的表达(均P< 0.05).此外,EPO治疗还能下调大鼠Scr、BUN和尿蛋白水平(均P<0.05),上调Hb水平(P<0.05).结论 EPO能改善慢性肾衰竭大鼠的肾功能,这种作用可能与其激活残肾组织归巢因子而参与损伤肾脏的修复有关.
目的 觀察紅細胞生成素(EPO)對慢性腎衰竭(CRF)大鼠腎組織歸巢因子錶達的影響.方法 採用分階段5/6腎切除製備大鼠CRF模型.實驗動物隨機分為3組:假手術組、CRF模型組和EPO治療組.從第3週開始,治療組大鼠每次皮下註射重組人EPO 50 IU/kg,每週3次,共6週.8週後檢測各組大鼠血肌酐(Scr)、血尿素氮(BUN)、尿蛋白、血紅蛋白(Hb);採用實時熒光定量PCR、Western印跡和免疫組化方法檢測殘腎組織EPO及其受體(EPOR)、歸巢因子及其受體(SDF-1、CXCR4、Ang-1、Tie2、SCF、c-Kit)的錶達.結果 與模型組比較,EPO治療可上調殘腎組織歸巢因子及其受體(SDF-1、CXCR4、Ang-1、Tie2、SCF、c-Kit)mRNA和蛋白的錶達(均P<0.05);同時,EPO治療還可上調殘腎組織EPO及EPOR的mRNA和蛋白的錶達(均P< 0.05).此外,EPO治療還能下調大鼠Scr、BUN和尿蛋白水平(均P<0.05),上調Hb水平(P<0.05).結論 EPO能改善慢性腎衰竭大鼠的腎功能,這種作用可能與其激活殘腎組織歸巢因子而參與損傷腎髒的脩複有關.
목적 관찰홍세포생성소(EPO)대만성신쇠갈(CRF)대서신조직귀소인자표체적영향.방법 채용분계단5/6신절제제비대서CRF모형.실험동물수궤분위3조:가수술조、CRF모형조화EPO치료조.종제3주개시,치료조대서매차피하주사중조인EPO 50 IU/kg,매주3차,공6주.8주후검측각조대서혈기항(Scr)、혈뇨소담(BUN)、뇨단백、혈홍단백(Hb);채용실시형광정량PCR、Western인적화면역조화방법검측잔신조직EPO급기수체(EPOR)、귀소인자급기수체(SDF-1、CXCR4、Ang-1、Tie2、SCF、c-Kit)적표체.결과 여모형조비교,EPO치료가상조잔신조직귀소인자급기수체(SDF-1、CXCR4、Ang-1、Tie2、SCF、c-Kit)mRNA화단백적표체(균P<0.05);동시,EPO치료환가상조잔신조직EPO급EPOR적mRNA화단백적표체(균P< 0.05).차외,EPO치료환능하조대서Scr、BUN화뇨단백수평(균P<0.05),상조Hb수평(P<0.05).결론 EPO능개선만성신쇠갈대서적신공능,저충작용가능여기격활잔신조직귀소인자이삼여손상신장적수복유관.
Objective To investigate the effect of erythropoietin (EPO) on the expression of homing factors of remnant renal tissue from rats with chronic kidney failure (CRF).Methods The CRF model was established by a two stage 5/6 nephrectomy procedure in rats.Experimental rats were randomly divided into three groups:sham operation group,CRF model group,EPO treatment group (CRF rats treated with human recombinant EPO).CRF rats received EPO by hypodermic injection with 50 IU/kg three times a week for 6 weeks and then were sacrificed.Serum creatinine (Scr),blood urea nitrogen (BUN),urine protein and haematoglobin (Hb) were measured.The expression of EPO and its receptor (EPOR),homing factors and their receptors (SDF-1,CXCR4,Ang-1,Tie2,SCF,c-Kit) in remnant kidney tissue were detected by the methods of real-time PCR,Western blotting and immunohistochemistry.Results Compared with CRF model group,the expressions of homing factors and their receptors (SDF-1,CXCR4,Ang-1,Tie2,SCF,c-Kit) in remnant kidney tissue were upregulated by administration of EPO in treatment group (all P < 0.05).Meanwhile,the expressions of EPO and its receptor in remnant kidney tissue were also up-regulated by administration of EPO in treatment group (all P < 0.05).Moreover,the Scr,BUN and urine protein in EPO treatment group were lower than those in CRF model group (all P < 0.05).Instead,haematoglobin was higher than that in CRF model group (P < 0.05).Conclusion EPO can improve renal function in rats with chronic renal failure,maybe through activation of homing factors in remnant kidney tissue which are involved in repairing damaged kidney.